Ipramid Inhaler 20 mcg/puff contains Ipratropium Bromide, an anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD) and as an adjunct therapy in certain cases of bronchial asthma. It works by relaxing the smooth muscles of the airways, leading to improved airflow and relief from bronchospasm. Ipramid Inhaler provides targeted delivery of medication directly to the lungs, ensuring rapid onset of action with minimal systemic effects.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Anticholinergic Bronchodilators
Respiratory Agents

Composition

Each metered dose delivers Ipratropium Bromide 20 mcg per puff.

Indications

Ipramid Inhaler 20 mcg/puff is indicated for:

• Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema

• Adjunctive therapy in the management of bronchial asthma

• Relief of reversible bronchospasm in patients with airway obstructive diseases

It is suitable for regular use as prescribed to maintain airway patency and improve respiratory function.

Pharmacology

Ipratropium Bromide is a quaternary ammonium anticholinergic agent that inhibits muscarinic receptors in the bronchial smooth muscle. By blocking the action of acetylcholine, it prevents bronchoconstriction and promotes bronchodilation. Ipratropium acts locally in the lungs and has minimal absorption into the systemic circulation, which reduces the risk of systemic anticholinergic side effects. The bronchodilatory effect begins within minutes after inhalation and lasts for several hours.

Dosage and Administration

The dosage of Ipramid Inhaler should be individualized according to the patient’s condition and response to therapy.

• Typically administered as one or two puffs several times daily as directed by a physician

• Patients should be instructed on proper inhalation technique to ensure effective drug delivery

The inhaler should be used regularly for maintenance therapy and not as a sole rescue medication for acute severe bronchospasm unless advised by a healthcare professional.

Contraindications

Ipramid Inhaler 20 mcg/puff is contraindicated in patients with:

• Known hypersensitivity to ipratropium bromide or atropine and its derivatives

• History of allergic reactions to any component of the formulation

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Use with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, or bladder neck obstruction

• Avoid contact of the aerosol with the eyes, as it may cause eye irritation or precipitate glaucoma symptoms

• Not intended for rapid relief of acute asthma attacks

Adverse Effects

Ipramid Inhaler is generally well tolerated. Possible adverse effects include:

• Dry mouth

• Throat irritation

• Cough

• Headache

• Rarely, paradoxical bronchospasm

Most side effects are mild and transient.

Drug Interactions

Ipratropium Bromide may be used concomitantly with beta-agonist bronchodilators and inhaled corticosteroids. Caution is advised when combined with other anticholinergic agents, as additive effects may occur.

Storage

Store in a cool and dry place, away from direct heat and sunlight. Do not puncture or expose the canister to high temperatures. Keep out of reach of children.

Conclusion

Ipramid Inhaler 20 mcg/puff is a safe and effective anticholinergic bronchodilator that plays an important role in the long-term management of COPD and other obstructive airway disorders. Its targeted action, good tolerability, and ease of use make it a valuable option for maintaining improved airflow and respiratory comfort.